PD-L1 is commonly expressed and transcriptionally regulated by STAT3 and MYC in ALK-negative anaplastic large-cell lymphoma

被引：156
|
作者：
Atsaves, V. [1 ]
Tsesmetzis, N. [1 ]
Chioureas, D. [1 ]
Kis, L. [1 ,2 ]
Leventaki, V. [3 ]
Drakos, E. [4 ]
Panaretakis, T. [1 ]
Grander, D. [1 ]
Medeiros, L. J. [5 ]
Young, K. H. [5 ]
Rassidakis, G. Z. [1 ,2 ,5 ]
机构：
[1] Karolinska Inst, Canc Ctr Karolinska, Dept Oncol & Pathol, Stockholm, Sweden
[2] Karolinska Univ Hosp, Dept Pathol & Cytol, Stockholm, Sweden
[3] St Jude Childrens Res Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA
[4] Univ Crete, Med Sch, Dept Pathol, Iraklion, Crete, Greece
[5] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA
来源：
LEUKEMIA | 2017年 / 31卷 / 07期
关键词：
KINASE; SURVIVAL; HODGKIN;
D O I：
10.1038/leu.2017.103
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1633 / 1637
页数：6
相关论文
共 50 条
  • [1] PD-L1 is commonly expressed and transcriptionally regulated by STAT3 and MYC in ALK-negative anaplastic large-cell lymphoma
    V Atsaves
    N Tsesmetzis
    D Chioureas
    L Kis
    V Leventaki
    E Drakos
    T Panaretakis
    D Grander
    L J Medeiros
    K H Young
    G Z Rassidakis
    Leukemia, 2017, 31 : 1633 - 1637
  • [2] PD-L1 Is Commonly Expressed and Transcriptionally Regulated by STAT3 and MYC in ALK-Negative Anaplastic Large Cell Lymphoma
    Atsaves, Vasillios
    Tsesmetzis, Nikolaos
    Chioureas, Dimitrios
    Kis, Lorand
    Leventaki, Vasiliki
    Drakos, Elias
    Panaretakis, Theocharis
    Medeiros, L. Jeffrey
    Rassidakis, George
    MODERN PATHOLOGY, 2017, 30 : 337A - 337A
  • [3] PD-L1 Is Commonly Expressed and Transcriptionally Regulated by STAT3 and MYC in ALK-Negative Anaplastic Large Cell Lymphoma
    Atsaves, Vasillios
    Tsesmetzis, Nikolaos
    Chioureas, Dimitrios
    Kis, Lorand
    Leventaki, Vasiliki
    Drakos, Elias
    Panaretakis, Theocharis
    Medeiros, L. Jeffrey
    Rassidakis, George
    LABORATORY INVESTIGATION, 2017, 97 : 337A - 337A
  • [4] ALK-negative anaplastic large-cell lymphoma
    Gaulard, Philippe
    de Leval, Laurence
    BLOOD, 2016, 127 (02) : 175 - +
  • [5] Composite ALK-negative anaplastic large-cell lymphoma and mantle cell lymphoma
    Pina-Oviedo, Sergio
    Motwani, Pooja
    BLOOD, 2023, 141 (05) : 556 - 556
  • [6] Skin involvement in ALK-negative systemic anaplastic large-cell lymphoma
    Hoshina, Daichi
    Arita, Ken
    Mizuno, Osamu
    Fujimoto, Katsuya
    Nishio, Mitsufumi
    Kondo, Takeshi
    Abe, Riichiro
    Shimizu, Hiroshi
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 67 (04) : E159 - E160
  • [7] Progress in the identification of subgroups in ALK-negative anaplastic large-cell lymphoma
    Boddicker, Rebecca L.
    Feldman, Andrew L.
    BIOMARKERS IN MEDICINE, 2015, 9 (08) : 719 - 722
  • [8] PD-L1 expression is associated with ALK positivity and STAT3 activation, but not outcome in patients with systemic anaplastic large cell lymphoma
    Shen, Jing
    Li, Shaoying
    Medeiros, L. Jeffrey
    Lin, Pei
    Wang, Sa A.
    Tang, Guilin
    Yin, C. Cameron
    You, M. James
    Khoury, Joseph D.
    Iyer, Swaminathan P.
    Miranda, Roberto N.
    Xu, Jie
    MODERN PATHOLOGY, 2020, 33 (03) : 324 - 333
  • [9] ALK-negative anaplastic large-cell lymphoma (ALCL) presenting as symmetrical axillary nodules
    Bouchard, Jeremy
    Lachance, Madeleine
    Delisle, Bernard
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB137 - AB137
  • [10] Prognostic factors of ALK-negative anaplastic large-cell lymphoma: a single-institution experience
    Raoudha Doghri
    Linda Bel HadjKacem
    Yoldez Houcine
    Lamia Charfi
    Maha Driss
    Karima Kacem
    Nadia Boujelbene
    Karima Mrad
    Annals of Hematology, 2018, 97 : 725 - 726
12345